Skip to content
10-K

Annual Report

Dthera Sciences

0001683168-18-000876

← back to feed
Filed
Apr 2, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Mar 29, 2018 50.34M sh
Operating Cash Flow FY 2017 · Dec 31, 2017 −$2.13M
Operating Cash Flow FY 2017 · Dec 31, 2016 −$441.85K
Short Term Debt FY 2017 · Dec 31, 2017 $0
Short Term Debt FY 2017 · Dec 31, 2016 $20K
Cash And Equivalents FY 2017 · Dec 31, 2017 $323.48K
Cash And Equivalents FY 2017 · Dec 31, 2016 $12.19K
Cash And Equivalents FY 2017 · Dec 31, 2015 $27.24K
Stockholders Equity FY 2017 · Dec 31, 2017 $60.25K
Stockholders Equity FY 2017 · Dec 31, 2016 −$579.83K
Stockholders Equity FY 2017 · Dec 31, 2015 −$696.1K
Current Liabilities FY 2017 · Dec 31, 2017 $438.27K
Current Liabilities FY 2017 · Dec 31, 2016 $593.93K
Total Liabilities FY 2017 · Dec 31, 2017 $438.27K
Total Liabilities FY 2017 · Dec 31, 2016 $593.93K
Current Assets FY 2017 · Dec 31, 2017 $421.16K
Current Assets FY 2017 · Dec 31, 2016 $13.19K
Total Assets FY 2017 · Dec 31, 2017 $498.52K
Total Assets FY 2017 · Dec 31, 2016 $14.11K
Sga Expense FY 2017 · Dec 31, 2017 $1.81M
Sga Expense FY 2017 · Dec 31, 2016 $690.25K
Rd Expense FY 2017 · Dec 31, 2017 $0
Rd Expense FY 2017 · Dec 31, 2016 $0
Net Income FY 2017 · Dec 31, 2017 −$2.56M
Net Income FY 2017 · Dec 31, 2016 −$1.19M
Operating Income FY 2017 · Dec 31, 2017 −$2.42M
Operating Income FY 2017 · Dec 31, 2016 −$1.04M
Gross Profit FY 2017 · Dec 31, 2017 $0
Gross Profit FY 2017 · Dec 31, 2016 $0
Revenue FY 2017 · Dec 31, 2017 $0
Revenue FY 2017 · Dec 31, 2016 $0